| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $56K | — | +449.1% |
| Cost of Revenue | $2K | — | -74.2% |
| Gross Profit | $54K | — | +7901.5% |
| R&D Expense | $794K | — | +38.2% |
| SG&A Expense | $1.1M | — | -20.7% |
| Operating Income | -$3.5M | — | +1.7% |
| Net Income | -$3.4M | — | -11.0% |
| EPS (Basic) | -$0.08 | — | +75.8% |
| EPS (Diluted) | -$0.08 | — | +75.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $723K | -1.2% | — |
| Inventory | $211K | -1.2% | — |
| Current Assets | $4.8M | -39.7% | -39.0% |
| Total Assets | $80.7M | -4.2% | -24.2% |
| Current Liabilities | $2.8M | +2.5% | -62.4% |
| Total Liabilities | $13.8M | -1.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | — | +1.3% |
| Financing Cash Flow | -$200K | — | -104.3% |
| -45.1% |
| Stockholders' Equity | $66.8M | -4.7% | -17.7% |